Professor Warns: Nigeria's Imported Drug Dependence Strains Economy, Calls for Biotech Investment
A professor of Microbiology, Simiat Olanike Jimoh, has issued a stark warning that Nigeria's heavy reliance on imported pharmaceuticals, polymers, and bio-based chemicals is placing significant pressure on the country's foreign reserves. She called for urgent investment in local production through biotechnology to address this critical issue.
Inaugural Lecture Highlights Economic Concerns
Jimoh raised these concerns while delivering the first inaugural lecture at the Federal University of Health Sciences, Ila-Orangun, Osun State. Her lecture, titled 'Fermenting the Future: Harnessing Microbial Metabolism for Sustainable Biotechnological Innovations', emphasized the unsustainable nature of Nigeria's current import dependency.
She noted that the continued importation of essential drugs, polymers, and other bio-based chemicals has not only undermined Nigeria's industrial independence but has also contributed to persistent foreign exchange outflows. According to her, this situation is particularly unsustainable amid current economic challenges and the pressing need to strengthen domestic production capacity.
Nigeria's Untapped Resources
Jimoh stressed that Nigeria possesses the necessary resources to reverse this troubling trend if the country invests strategically in microbial biotechnology and related industries. "Nigeria has abundant agricultural residues and a rich pool of indigenous microbial diversity that can be harnessed to produce pharmaceuticals and other high-value products locally," she explained.
"If properly developed, these resources can reduce our dependence on imports and ease the pressure on foreign reserves," she added, highlighting the potential economic benefits of developing domestic biotechnological capabilities.
Healthcare Financing Crisis
Meanwhile, health policy experts have called for a comprehensive overhaul of Nigeria's healthcare financing system. They warn that millions of Nigerian citizens are being priced out of essential medical services due to heavy reliance on out-of-pocket payments and alarmingly low insurance coverage.
These experts made their urgent call during a webinar hosted by SYNLAB Nigeria, themed 'Enabling Healthcare Financing for Complete Patient Care'. Stakeholders at the event highlighted the critical reforms needed to make healthcare more accessible, affordable, and prevention-driven across the nation.
Alarming Statistics Revealed
According to data cited during the webinar, Nigeria funds approximately 70 percent of its healthcare through direct household spending, while fewer than 10 percent of citizens are covered by any form of health insurance. This financing model, experts noted, creates several serious problems:
- Discourages early care-seeking behavior
- Often pushes families into poverty when serious illness occurs
- Creates barriers to accessing essential medications
- Undermines preventive healthcare initiatives
The combination of imported pharmaceutical dependency and inadequate healthcare financing represents a dual challenge for Nigeria's health sector. Both issues require immediate attention and strategic investment to ensure sustainable healthcare delivery and economic stability.
